Literature DB >> 23661017

Induction of differentiation by down-regulation of Nanog and Rex-1 in cord blood derived unrestricted somatic stem cells.

Lida Langroudi1, Mehdi Forouzandeh, Masoud Soleimani, Amir Atashi, Azadeh Fahim Golestaneh.   

Abstract

Stem cells with high self-renewal and tissue regeneration potentials are the core components of regenerative medicine. Adult stem cells with many available sources, high repairing ability, and also possessing no ethical issues are popular candidates in the clinical field. In this study we looked upon the effects of two transcription factors Nanog and Rex-1 in self-renewal and differentiation abilities of a subpopulation of cord blood stem cells known as unrestricted somatic stem cells (USSCs). USSCs were expanded and transfected in vitro with siRNAs targeting either Nanog, Rex-1, and in combination. Gene suppressions were achieved at both transcript and proteome level. Differentiations were evaluated by specific Real time PCR and differentiating staining. Nanog knock down revealed a significant increase in osteogenic markers, Osteocalcin and Osteopontin expression as well as a positive Alizarin Red staining, which proposes Osteogenesis. This treatment also became positive for Oil Red staining, implying adipogenic differentiation as well. In contrast, Rex-1 knock down showed an increase in MAP II and Nestin expression, which is a hall mark of neural differentiation. Surprisingly, treatment with both siRNAs did not express any changes in any of the assessed markers. Therefore, our results indicated a bilateral mesenchymal differentiation for Nanog and a neural lineage fate for Rex-1 suppression. Considering that both transcription factors are core activators of self-renewal and also are orchestrating with other factors, our results imply a positive feedback in response to changes in the regulatory network of self-renewal.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661017     DOI: 10.1007/s11033-013-2533-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 2.  Approaches for chemically synthesized siRNA and vector-mediated RNAi.

Authors:  Mohammed Amarzguioui; John J Rossi; Dongho Kim
Journal:  FEBS Lett       Date:  2005-09-20       Impact factor: 4.124

Review 3.  Stem cell therapy-present status.

Authors:  H M Aejaz; A K Aleem; N Parveen; M N Khaja; M Lakshmi Narusu; C M Habibullah
Journal:  Transplant Proc       Date:  2007-04       Impact factor: 1.066

Review 4.  Embryonic and adult stem cell therapy.

Authors:  Anne C Brignier; Alan M Gewirtz
Journal:  J Allergy Clin Immunol       Date:  2010-01-12       Impact factor: 10.793

5.  Regulation of the pluripotency marker Rex-1 by Nanog and Sox2.

Authors:  Wenjing Shi; Hui Wang; Guangjin Pan; Yijie Geng; Yunqian Guo; Duanqing Pei
Journal:  J Biol Chem       Date:  2006-05-21       Impact factor: 5.157

6.  Enhanced osteogenic differentiation of cord blood-derived unrestricted somatic stem cells on electrospun nanofibers.

Authors:  Ehsan Seyedjafari; Masoud Soleimani; Nasser Ghaemi; Mohammad Nabi Sarbolouki
Journal:  J Mater Sci Mater Med       Date:  2010-11-11       Impact factor: 3.896

Review 7.  Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.

Authors:  Vasundhra Kashyap; Naira C Rezende; Kymora B Scotland; Sebastian M Shaffer; Jenny Liao Persson; Lorraine J Gudas; Nigel P Mongan
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

Review 8.  Cell and gene therapy using mesenchymal stem cells (MSCs).

Authors:  Keiya Ozawa; Kazuya Sato; Iekuni Oh; Katsutoshi Ozaki; Ryosuke Uchibori; Yoko Obara; Yuji Kikuchi; Takayuki Ito; Takashi Okada; Masashi Urabe; Hiroaki Mizukami; Akihiro Kume
Journal:  J Autoimmun       Date:  2008-01-31       Impact factor: 7.094

9.  Influence of different culture solutions on osteoblastic differentiation in cord blood and bone marrow derived progenitor cells.

Authors:  M Jäger; A Wild; S Lensing-Höhn; R Krauspe
Journal:  Biomed Tech (Berl)       Date:  2003-09       Impact factor: 1.411

10.  Human cord blood-derived cells attain neuronal and glial features in vitro.

Authors:  L Buzańska; E K Machaj; B Zabłocka; Z Pojda; K Domańska-Janik
Journal:  J Cell Sci       Date:  2002-05-15       Impact factor: 5.285

View more
  3 in total

1.  MiR-371-373 cluster acts as a tumor-suppressor-miR and promotes cell cycle arrest in unrestricted somatic stem cells.

Authors:  Lida Langroudi; Fatemeh Jamshidi-Adegani; Abbas Shafiee; Seyed Mohammad Ali Hosseini Rad; Farid Keramati; Kayhan Azadmanesh; Ehsan Arefian; Masoud Soleimani
Journal:  Tumour Biol       Date:  2015-05-05

2.  Inhibition of breast cancer metastasis by co-transfection of miR-31/193b-mimics.

Authors:  Zahra Sadat Hashemi; Mehdi Forouzandeh Moghadam; Samila Farokhimanesh; Masoumeh Rajabibazl; Esmaeil Sadroddiny
Journal:  Iran J Basic Med Sci       Date:  2018-04       Impact factor: 2.699

3.  miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway.

Authors:  Huanrong Zhang; Rong Wang; Qiuhua Deng
Journal:  Comput Math Methods Med       Date:  2022-08-14       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.